The Philippines is in the grip of its largest HIV outbreak on record, with 57 new infections reported every day, nearly a third of them among people below 18 years old, Health Secretary Ted Herbosa ...

As the annual U.S. Conference on HIV/AIDS (USCHA) kicks off in Washington, D.C., this week with a focus on aging with HIV, Gilead Sciences is rolling out a corresponding awareness campaign ...

In September 2021, Victoria Roscow from Manchester received a diagnosis of Human Immunodeficiency Virus (HIV) when she was nine weeks pregnant with her son. Since then, she's used social media to ...

The intervention increased HIV cotesting rates in urgent care and emergency departments, improving diagnosis and care linkage. Electronic prompts for HIV tests during STI evaluations led to ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...

The authors do not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and have disclosed no relevant affiliations beyond their ...

The National Institutes of Health placed a big bet on Oregon scientist Jonah Sacha this week, awarding Sacha and his colleagues an $8.4 million, five-year grant for their work developing a cure for ...

Meeting UNAIDS’ “95/95/95” targets for 2025—95% of people with HIV knowing their status, 95% of those who know their status on treatment, and 95% of people on treatment having a suppressed viral ...

Lenacapavir approved for PrEP in EU, Norway, Iceland, Liechtenstein Pricing, reimbursement to be determined with each country Gilead's lenacapavir nearly 100% effective in trials Aug 26 (Reuters) - ...

JOHANNESBURG (AP) — On a warm evening in Johannesburg, the news spread like wildfire among sex workers: Within 24 hours, several nonprofit clinics providing free HIV services would be closing as ...

CVS cites clinical, financial, and regulatory reasons for decision Yeztugo approved by FDA in June, nearly 100% effective in trials Medicare, VA, some Medicaid plans are already covering the drug CVS ...